Legal Representation
Attorney
Christina M. Licursi
USPTO Deadlines
Application History
47 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 22, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 22, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Feb 29, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 29, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 29, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 26, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 15, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 13, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 13, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 13, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 24, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 22, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 22, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 22, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 14, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 23, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 21, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 21, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 21, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 22, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 25, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 25, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 5, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 22, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 22, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 22, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 22, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 14, 2021 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Jul 14, 2021 | GEAP | O | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Jul 14, 2021 | EPEN | O | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | Loading... |
| Jul 14, 2021 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Jul 12, 2021 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jun 8, 2021 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| May 25, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 25, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 25, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 25, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 25, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 25, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 20, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 19, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 19, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 1, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 1, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 1, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 1, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 9, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits and preparations for use in the treatment and diagnosis of cancer
Class 042
Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
Class 044
Diagnostic services for use in the treatment and diagnosis of cancer
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ONCOLOGY"